Guide

Lu-177-PSMA manufacturing readiness

Lu-177-PSMA-617 (Pluvicto, approved by FDA 2022 and EMA 2023) is the highest-profile theranostic radiopharmaceutical in the world, and the supply chain has been the single biggest growth constraint for metastatic castration-resistant prostate cancer treatment. With a 6.7-day half-life, Lu-177 sits between the seconds-to-minutes regime of PET tracers and conventional cold-chain pharmaceuticals. Manufacturing is governed by 21 CFR 211 (not 212), EudraLex Annex 3, and ICH Q7 for the peptide precursor. This guide covers the operating model for centralized production sites — Novartis's two AAA facilities (Ivrea, Italy and Millburn, NJ), POINT Biopharma's Indianapolis site, and the new generation of CDMOs scaling for Lu-177-DOTATATE, Lu-177-FAPI, and Lu-177-J591.

Start free trial Free trial, no credit card, onboard in days, not months.

n.c.a. vs c.a. Lu-177 — the supply decision

Lu-177 comes in two forms. Carrier-added (c.a.) Lu-177 is produced by direct neutron activation of Lu-176 in a reactor — high availability but contaminated with long-lived Lu-177m and stable Lu-176. No-carrier-added (n.c.a.) Lu-177 is produced from Yb-176 via Yb-177 decay, giving very high specific activity and no Lu-177m. Pluvicto is n.c.a. ITM, Eckert & Ziegler, ORNL, and ANSTO are the main n.c.a. suppliers; reactor lead-times and Yb-176 enrichment capacity are the binding constraints on global theranostic scale-up.

Peptide precursor and radiolabeling

The PSMA-617 cold precursor is a Glu-urea-Lys-based peptide manufactured under ICH Q7 — supplied by a handful of peptide CDMOs (Bachem, PolyPeptide, ABL). Radiolabeling occurs in a shielded hot cell using automated synthesis modules (Eckert & Ziegler Modular-Lab, Trasis AllInOne, Comecer Taddeo): Lu-177 chloride is heated with the precursor in a buffered solution, then purified by solid-phase extraction. Reaction time 15–30 minutes, batch sizes typically 20–100 GBq.

QC and radiochemical purity

Release specification typically requires radiochemical purity ≥95% by HPLC and ITLC, radionuclidic purity confirmed by gamma spectroscopy, pH 4.5–7.5, endotoxin <2.5 EU/dose, and bioburden / sterility. The HPLC method is the most sensitive control point — column equilibration and reference standard availability for free Lu-177-DTPA are the typical bottlenecks. With a 6.7-day half-life, sterility test results return well after release, so the model is conditional release with post-release sterility follow-up similar to PET — but the activity decay window is days, not hours.

Centralized vs dose-on-demand

Pluvicto is centralized: patient-specific doses are manufactured to order, dispensed decay-corrected to the scheduled administration time, and shipped under Class 7 transport regulations to the treating center. Dose-on-demand at the hospital cyclotron / hot-cell scale (closer to the PET model) is being piloted for shorter-half-life theranostics (Ga-68-PSMA, Ac-225-PSMA) but is not yet viable for Lu-177-PSMA at clinical-trial scale outside academic centers.

Supply chain and patient scheduling

The decay-corrected dispense forces the manufacturing site to operate against patient-treatment slots booked 5–7 days ahead. Any production failure, transport delay, or treatment cancellation results in scrap — no return-to-stock is possible. Yield management and overbooking models, borrowed from airline operations, have become a core operational discipline at Lu-177 manufacturers. V5 Ultimate's radiopharma playbook models this as a single integrated flow from precursor receipt to administered dose.

Standards covered in this guide

Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.

21 CFR 211

The FDA cGMP rule that governs every step of finished-drug manufacturing — facilities, equipment, components, production, packaging, labels, lab controls, records and complaints.

ICH Q7

The international GMP standard for API manufacture — adopted as FDA guidance and EU GMP Part II.

ICH Q10

The international model for a Pharmaceutical Quality System covering the entire product lifecycle from development to discontinuation.

ALCOA+

The nine-letter mnemonic regulators use to grade your data integrity — and what every Part 11 audit really tests.

CAPA

Structured investigation + fix loop for recurring problems — required by every quality regime.

Where this lives in V5 Ultimate

The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.

Industries this hits hardest

Frequently asked

Why is n.c.a. Lu-177 supply so constrained?

Only a handful of research reactors worldwide (BR2 in Belgium, HFR Petten, MURR, ANSTO OPAL, NRG Petten, SAFARI) can irradiate enriched Yb-176, and reactor cycles are 4–6 weeks. Yb-176 itself requires uranium-style centrifuge enrichment from natural Yb (12.7% Yb-176). The supply curve is reactor-cycle-bound, not demand-bound.

Can we use c.a. Lu-177 for Pluvicto?

No — the approved product is n.c.a. and the FDA / EMA filings reference n.c.a. specifications. c.a. Lu-177 is used for some research, sealed-source applications, and in some non-PSMA radiopharmaceutical pipelines.

How is patient-specific dose calculated?

Pluvicto is a fixed-activity product (7.4 GBq per administration), so 'patient-specific' here means dispensed and decay-corrected for that patient's administration time slot, not patient-specific in activity. Investigational dosimetry-guided therapy regimens that calculate per-patient activity are emerging in clinical trials.

What is the inspection model?

FDA inspects against 21 CFR 211 cGMP with radiopharma guidance overlays. EMA-coordinated national-competent-authority inspections enforce EU GMP Part I plus Annex 1 (sterile) and Annex 3 (radiopharmaceuticals). Inspections concentrate on radiochemical purity method robustness, sterility-test follow-up procedure, supplier qualification of the cold precursor and the Lu-177, and patient-specific dispense records.

See it on your shop floor.

Free trial, no credit card, onboard in days, not months.

Start free trial See pricing →Browse all resources →